CV outcomes with a PCSK9 inhibitor: FOURIER study - PACE-CME

CV outcomes with a PCSK inhibitor FOURIER study

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Troponin is an independent predictor of CV events at non-cardiac surgery
Troponin is an independent predictor of CV events at non-cardiac surgery
ACC.17
Troponin is an independent predictor of CV events at non-cardiac surgery
- Dr. P.J. Devereaux
E-counselling improves adherence in hypertensives
E-counselling improves adherence in hypertensives
ACC.17
E-counselling improves adherence in hypertensives
- Dr. Rob Nolan
PCI-registry-based trial shows that IFR is non-inferior to FFR, with reduced discomfort and stenting
PCI-registry-based trial shows that IFR is non-inferior to FFR, with reduced discomfort and stenting
ACC.17
PCI-registry-based trial shows that IFR is non-inferior to FFR, with reduced discomfort and stenting
Identification of patients who will benefit is important after FOURIER
Identification of patients who will benefit is important after FOURIER
ACC.17
Identification of patients who will benefit is important after FOURIER
- Prof. Ulf Landmesser